These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8754434)

  • 21. Why women quit using Depo-Provera?
    Tinkle M; Reifsnider E; Ransom SP
    AWHONN Lifelines; 2001 Dec-2002 Jan; 5(6):36-41. PubMed ID: 11778463
    [No Abstract]   [Full Text] [Related]  

  • 22. [Contraception with Depo-Provera. Report of a series of 930 women].
    Mahjoub S; Lebbi I; Dakhli R; Smaïli L; Ben Hmjd R; Ben Romdhane M; Zouari F; Hamzaoui R
    Tunis Med; 2000 Nov; 78(11):662-6. PubMed ID: 11155390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Compliance with depot medroxyprogesterone acetate: a randomized, controlled trial of intensive reminders.
    Keder LM; Rulin MC; Gruss J
    Am J Obstet Gynecol; 1998 Sep; 179(3 Pt 1):583-5. PubMed ID: 9757955
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adolescents' reasons for and experience after discontinuation of the long-acting contraceptives Depo-Provera and Norplant.
    Harel Z; Biro FM; Kollar LM; Rauh JL
    J Adolesc Health; 1996 Aug; 19(2):118-23. PubMed ID: 8863083
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunosuppressive biological mechanisms support reassessment of use of the injectable contraceptive medroxyprogesterone acetate.
    Hapgood JP
    Endocrinology; 2013 Mar; 154(3):985-8. PubMed ID: 23429710
    [No Abstract]   [Full Text] [Related]  

  • 26. Depo-Provera: an ideal contraceptive for adolescents?
    Boroditsky RS
    J Pediatr Adolesc Gynecol; 1999 May; 12(2):95-9. PubMed ID: 10326195
    [No Abstract]   [Full Text] [Related]  

  • 27. Striae from DEPO-PROVERA injections.
    Harris D; Ridley CM
    Clin Exp Dermatol; 1996 Mar; 21(2):172. PubMed ID: 8759213
    [No Abstract]   [Full Text] [Related]  

  • 28. Depot-medroxyprogesterone acetate: an update.
    Bakry S; Merhi ZO; Scalise TJ; Mahmoud MS; Fadiel A; Naftolin F
    Arch Gynecol Obstet; 2008 Jul; 278(1):1-12. PubMed ID: 18470526
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Depo-Provera Versus Norethisterone Acetate in Management of Endometrial Hyperplasia Without Atypia.
    Nooh AM; Abdeldayem HM; Girbash EF; Arafa EM; Atwa K; Abdel-Raouf SM
    Reprod Sci; 2016 Apr; 23(4):448-54. PubMed ID: 26718306
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contraception and antiepileptic drugs.
    Guillemette T; Yount SM
    J Midwifery Womens Health; 2012; 57(3):290-5. PubMed ID: 22587648
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Depo-Provera in adolescents: effects of early second injection or prior oral contraception.
    Harel Z; Biro FM; Kollar LM
    J Adolesc Health; 1995 May; 16(5):379-84. PubMed ID: 7662688
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Depression in users of depo-medroxyprogesterone acetate.
    Westhoff C; Wieland D; Tiezzi L
    Contraception; 1995 Jun; 51(6):351-4. PubMed ID: 7554975
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Depo-Provera: use of a long-acting progestin injectable contraceptive in Turkish women.
    Aktun H; Moroy P; Cakmak P; Yalcin HR; Mollamahmutoglu L; Danisman N
    Contraception; 2005 Jul; 72(1):24-7. PubMed ID: 15964288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Depo-Provera: new concerns--same issues?
    Robinson K
    AWHONN Lifelines; 2005; 9(3):214-7. PubMed ID: 16114743
    [No Abstract]   [Full Text] [Related]  

  • 35. Depo Provera: a profile of current users.
    Jarman H; Kovacs GT; Westcott M
    Aust N Z J Obstet Gynaecol; 1990 Feb; 30(1):74-6. PubMed ID: 2140675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of visible disruption of cervical epithelium and cervical ectopy in African women using Depo-Provera.
    Kuhn L; Denny L; Pollack AE; Wright TC
    Contraception; 1999 Jun; 59(6):363-7. PubMed ID: 10518230
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medroxyprogesterone acetate (Depo-Provera) and bone mineral density loss.
    Wooltorton E
    CMAJ; 2005 Mar; 172(6):746. PubMed ID: 15743913
    [No Abstract]   [Full Text] [Related]  

  • 38. Depo-Provera and bone density.
    Gbolade BA
    J Fam Plann Reprod Health Care; 2002 Jan; 28(1):7-11; quiz 11, 50. PubMed ID: 16259806
    [No Abstract]   [Full Text] [Related]  

  • 39. Depo-Provera: an injectable contraceptive.
    Earl DT; David DJ
    Am Fam Physician; 1994 Mar; 49(4):891-4, 897-8. PubMed ID: 8116522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New aspects of injectable contraception.
    Phillips OP
    Int J Fertil Womens Med; 2001; 46(1):31-6. PubMed ID: 11294618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.